Search

Search Constraints

You searched for: Author/Creator Idbaih, Ahmed

Search Results

1. 5-Azacitidine in patients with IDH1/2-mutant recurrent glioma. Issue 8 (26th March 2020)

2. 5th International Symposium on Focused Ultrasound. Issue 1 (November 2016)

3. 5th International Symposium on Focused Ultrasound. Issue 1 (November 2016)

4. A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries. (August 2020)

5. ACTR-57. A PHASE 1/2 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF BLOOD-BRAIN BARRIER (BBB) OPENING WITH A NINE-EMITTER IMPLANTABLE ULTRASOUND DEVICE IN RECURRENT GLIOBLASTOMA PATIENTS PRIOR TO CARBOPLATIN. (11th November 2019)

6. Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas. (13th October 2015)

7. An ANOCEF Genomic and Transcriptomic Microarray Study of the Response to Irinotecan and Bevacizumab in Recurrent Glioblastomas. (2nd April 2014)

9. Analysis of temozolomide resistance in low‐grade gliomas using a mechanistic mathematical model. (24th January 2017)

10. Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial. Issue 9 (September 2018)